SEDAR News:

Canadian Securities Regulators advises issuers and SEDAR.com users of recent changes to the availability of public regulatory filings on SEDAR.com.  Public regulatory filings are now accessible on SEDAR.com within fifteen minutes of the original submission through the SEDAR filing system.  New reporting issuer profiles that are made public, as well as updates to existing profiles, will also appear on SEDAR.com within 15 minutes of the original submission.



Bradmer Pharmaceuticals Inc.
Profile
Mailing Address: c/o Wildeboer Dellelce LLP
1 First Canadian Place, Suite 810
Toronto, Ontario
M5X 1A9
Head Office Address: c/o Wildeboer Dellelce LLP
1 First Canadian Place, Suite 810
Toronto, Ontario
M5X 1A9
Contact Name: Dr. Mark C. Rogers Principal Regulator: Ontario
Business e-mail address: Short Form Prospectus Issuer: No
Telephone Number: 416 361-3121 Reporting Jurisdictions: Ceased Reporting
Fax Number: 416 361-1790 Stock Exchange: N/A
Date of Formation: Jun 16 2005 Stock Symbol:
Jurisdiction Where Formed: Ontario Auditor: DMCT, LLP
Industry Classification: other General Partner:
CUSIP Number: 10463R Transfer Agent: Equity Transfer Services Inc.
Financial Year-End: Dec 31 Size of Issuer (Assets): Under $5,000,000


This company is a previous issuer to   Bradmer Pharmaceuticals Inc.
View This Public Company's Documents